Insurance Denial Letter

Reading Your Denial Letter: What the Language Actually Means

Insurance denial letters are written in language designed to sound authoritative and final. They cite plan provisions, clinical criteria, and coverage exclusions in ways that suggest the determination is settled. It is not. Every denial letter is the beginning of a process, not the conclusion of one. Understanding what the letter actually communicates — rather than what it implies — is the foundation of an effective appeal.

The most important element of any denial letter is the denial reason code and the specific clinical criteria cited as the basis for the denial. Insurance companies are required to provide the specific reason for each denial. When the denial is based on medical necessity, the letter must cite the specific clinical criteria applied and explain why the service did not meet those criteria. This explanation — however brief — tells an experienced case manager exactly what documentation and argument the appeal must address.

The denial letter is also required to include information about your appeal rights — the internal appeal process, the external review process, and the applicable deadlines. These sections are typically written in small print and positioned prominently as a technical disclosure rather than a practical guide. Our case managers treat these sections as the strategic map for your case.

Medical Necessity Denials: The Most Commonly Appealed Category

Medical necessity denials are issued when the insurer determines that a treatment, procedure, hospitalization, or service was not medically necessary according to the clinical criteria in the plan's coverage policy. These denials are the most commonly appealed category of insurance denials — and the category with the highest overturn rate at external review — because they involve a clinical judgment that frequently conflicts between the treating physician and the insurer's medical reviewer.

The clinical criteria insurers use to make medical necessity determinations are not the same as the clinical guidelines published by professional medical associations. Insurer criteria are proprietary — developed internally or licensed from third-party criteria developers — and are applied by reviewers who typically do not have the specialty training of the treating physician. The result is a systematic tendency to apply more conservative coverage standards than what practicing clinicians would consider medically appropriate for the patient's condition.

External reviewers are independent, board-certified physicians in the relevant specialty who review medical necessity disputes without any financial relationship with the insurer. Their perspective is clinical, not administrative, and they evaluate the appropriateness of care from the standpoint of a treating physician rather than an insurance administrator. This difference in perspective is why external review overturns insurer denials in 40–60% of cases — and why properly documented medical necessity appeals submitted to external review produce substantially better outcomes than unrepresented patients appealing on their own.

Not sure where to start? Get a free consultation — our case managers will review your situation at no cost.

Prior Authorization Denials: When the Gate Was Closed Before Care

Prior authorization denials are issued before or contemporaneous with the service — the insurer declines to authorize a treatment, medication, or procedure before it is provided. These denials are particularly consequential because they can prevent access to necessary care entirely, or force patients to proceed with care knowing that coverage may be denied and the resulting bill may fall to them.

Prior authorization denials are appealed using the same medical necessity framework as retrospective denials, with the additional option of an expedited appeal process for urgent clinical situations. When the clinical situation is urgent — the patient needs the denied treatment in a timeframe that does not allow for the standard appeal process — federal regulations require insurers to complete expedited appeal reviews within 72 hours and expedited external reviews within 72 hours of the request.

The most effective prior authorization appeals combine a strong medical necessity argument from the treating physician with a peer-to-peer review request — a direct conversation between the treating physician and the insurer's medical reviewer. Peer-to-peer reviews, when properly prepared, have a high overturn rate for prior authorization denials. Our case managers facilitate peer-to-peer reviews by preparing the treating physician with the specific clinical arguments and documentation that are most relevant to the insurer's denial rationale.

Experimental and Investigational Treatment Denials

Insurance plans routinely exclude coverage for treatments classified as "experimental" or "investigational." These denials are among the most consequential because they frequently involve serious diagnoses — cancer, rare diseases, complex conditions — where established treatments have failed and the patient is seeking access to a treatment that their physician believes represents the current standard of care.

The designation of a treatment as experimental or investigational is not permanent, and it varies significantly among insurers. A treatment that one insurer covers as standard of care may be denied by another insurer as investigational based on the same clinical literature. Appealing these denials requires compiling peer-reviewed clinical evidence demonstrating that the treatment is considered established — or at minimum, is recommended by relevant professional medical associations — for the patient's specific diagnosis and clinical circumstances.

External reviewers who specialize in the relevant clinical area are particularly well-positioned to evaluate experimental treatment denials, because they are practicing physicians who understand how the clinical literature applies to real patient cases. Our case managers compile the clinical evidence and frame it in the format most likely to be persuasive to an external reviewer in the relevant specialty.

MedErase handles this for you. Get a free consultation and our case managers will assess your specific bill.

Network and Coverage Denials

Coverage denials based on network status — claims denied because the provider or facility was out-of-network — require a different analysis than medical necessity denials. The central question in a network denial is not whether the care was clinically appropriate, but whether the patient had any realistic opportunity to access the care they needed within the network, and whether the billing complied with applicable network disclosure requirements.

Network adequacy disputes arise when a patient received out-of-network care because in-network alternatives were clinically inappropriate, unavailable in a reasonable timeframe, or geographically inaccessible. Most insurance plans have continuity of care and network adequacy provisions that require coverage for out-of-network care when in-network care is genuinely unavailable. Documenting and arguing these facts is a specific advocacy skill that our team applies to network denial cases.

External Review: The Appeal Level Most People Never Use

External Independent Medical Review is the most powerful appeal level available to patients — and the one most rarely used. An external reviewer is an independent physician, selected without insurer involvement, who reviews the clinical merits of your denial. The external reviewer's decision is binding on your insurer. If the reviewer overturns the denial, the insurer must pay the claim.

External review is available after the insurer's internal appeals are exhausted, or in cases of urgent clinical need, contemporaneously with the internal appeal. The external reviewer is selected by your state's insurance department or a federally accredited independent review organization, depending on the type of insurance plan. Our case managers prepare the external review submission with the same rigor as a clinical litigation brief — comprehensive clinical documentation, peer-reviewed literature, and a clear argument for why the insurer's determination was incorrect under the applicable clinical standard.